National Planning Corporation’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,853
| Closed | -$260K | – | 658 |
|
|
2017
Q3 | $260K | Buy |
+1,853
| New | +$260K | 0.02% | 558 |
|
|
2016
Q4 | – | Sell |
-3,263
| Closed | -$392K | – | 734 |
|
|
2016
Q3 | $392K | Sell |
3,263
-13
| -0.4% | -$1.56K | 0.03% | 413 |
|
|
2016
Q2 | $438K | Hold |
3,276
| – | – | 0.03% | 409 |
|
|
2016
Q1 | $462K | Sell |
3,276
-2,220
| -40% | -$313K | 0.04% | 370 |
|
|
2015
Q4 | $782K | Buy |
5,496
+113
| +2% | +$16.1K | 0.06% | 298 |
|
|
2015
Q3 | $945K | Sell |
5,383
-1,437
| -21% | -$252K | 0.09% | 220 |
|
|
2015
Q2 | $1.27M | Buy |
+6,820
| New | +$1.27M | 0.11% | 183 |
|
|
2015
Q1 | – | Sell |
-324
| Closed | -$60.9K | – | 2247 |
|
|
2014
Q4 | $60.9K | Sell |
324
-1,648
| -84% | -$310K | ﹤0.01% | 1164 |
|
|
2014
Q3 | $351K | Sell |
1,972
-500
| -20% | -$89K | 0.03% | 510 |
|
|
2014
Q2 | $386K | Sell |
2,472
-100
| -4% | -$15.6K | 0.03% | 496 |
|
|
2014
Q1 | $397K | Sell |
2,572
-200
| -7% | -$30.9K | 0.03% | 448 |
|
|
2013
Q4 | $367K | Sell |
2,772
-57
| -2% | -$7.55K | 0.03% | 466 |
|
|
2013
Q3 | $334K | Buy |
2,829
+22
| +0.8% | +$2.6K | 0.03% | 460 |
|
|
2013
Q2 | $258K | Buy |
+2,807
| New | +$258K | 0.03% | 423 |
|